Education
About Us
Working with TipRanks
Follow Us
Extrawell Pharmaceutical Holdings Limited (HK:0858)
:0858
0858 Stock Chart & Stats
HK$0.08
>-HK$0.01(-4.00%)
At close: 4:00 PM EST
HK$0.08
>-HK$0.01(-4.00%)
Day’s Range― - ―
52-Week RangeHK$0.04 - HK$0.15
Previous CloseN/A
Volume550.00K
Average Volume (3M)2.87M
Market Cap
HK$229.50M
Enterprise Value-HK$725.99M
Total Cash (Recent Filing)HK$870.44M
Total Debt (Recent Filing)HK$130.18M
Price to Earnings (P/E)1.0
Beta0.80
Next Earnings
Nov 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,550,000,000
10 Day Avg. Volume3,479,000
30 Day Avg. Volume2,870,000
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.08
Price to Sales (P/S)1.94
P/FCF Ratio-14.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Extrawell Pharmaceutical Holdings Limited News
0858 FAQ
What was Extrawell Pharmaceutical Holdings Limited’s price range in the past 12 months?
Extrawell Pharmaceutical Holdings Limited lowest stock price was HK$0.04 and its highest was HK$0.15 in the past 12 months.
What is Extrawell Pharmaceutical Holdings Limited’s market cap?
Extrawell Pharmaceutical Holdings Limited’s market cap is HK$229.50M.
When is Extrawell Pharmaceutical Holdings Limited’s upcoming earnings report date?
Extrawell Pharmaceutical Holdings Limited’s upcoming earnings report date is Nov 28, 2025 which is yesterday.
How were Extrawell Pharmaceutical Holdings Limited’s earnings last quarter?
Currently, no data Available
Is Extrawell Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Extrawell Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Extrawell Pharmaceutical Holdings Limited pay dividends?
Extrawell Pharmaceutical Holdings Limited does not currently pay dividends.
What is Extrawell Pharmaceutical Holdings Limited’s EPS estimate?
Extrawell Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Extrawell Pharmaceutical Holdings Limited have?
Extrawell Pharmaceutical Holdings Limited has 2,550,000,000 shares outstanding.
What happened to Extrawell Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Extrawell Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:0858
Extrawell Pharmaceutical Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.17%
12-Months-Change
Fundamentals
Return on Equity
23.02%
Trailing 12-Months
Asset Growth
18.58%
Trailing 12-Months
Company Description
Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited (0858) is a biopharmaceutical company based in Hong Kong, primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates within the healthcare sector, focusing on innovative therapies and medications, including prescription drugs and over-the-counter products. Extrawell's core offerings include a range of generic and proprietary medications aimed at treating various medical conditions, alongside its emphasis on enhancing drug delivery systems and formulations.
Technical Analysis
Qianhai Health Holdings Ltd.
―
Kontafarma China Holdings Ltd
―
PuraPharm Corp. Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Huakang Biomedical Holdings Company Limited
―